FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1499241000168101: lanadelumab 300 mg / 2 mL injection, 2 mL syringe (medicinal product unit of use)

Status: current, Defined. Date: 31-Oct 2020. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4469821000168115 lanadelumab 300 mg / 2 mL injection, 2 mL syringe (medicinal product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4469831000168117 lanadelumab 300 mg/2 mL injection, syringe en Synonym Active Case sensitive Australian Medicines Terminology module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
lanadelumab 300 mg/2 mL injection, syringe Is a lanadelumab true Inferred relationship Some
lanadelumab 300 mg/2 mL injection, syringe Is a medicinal product unit of use true Inferred relationship Some
lanadelumab 300 mg/2 mL injection, syringe has manufactured dose form injection true Inferred relationship Some
lanadelumab 300 mg/2 mL injection, syringe has Australian BoSS lanadelumab true Inferred relationship Some 1892667559
lanadelumab 300 mg/2 mL injection, syringe has intended active ingredient lanadelumab true Inferred relationship Some 1892667559
lanadelumab 300 mg/2 mL injection, syringe has unit of use syringe true Inferred relationship Some 1012174029
Inbound Relationships Type Active Source Characteristic Refinability Group
Takhzyro 300 mg/2 mL injection, 2 mL syringe Is a True lanadelumab 300 mg/2 mL injection, syringe Inferred relationship Some
lanadelumab 300 mg/2 mL injection, 2 mL syringe has MPUU True lanadelumab 300 mg/2 mL injection, syringe Inferred relationship Some 246813256

Reference Sets

Medicinal product unit of use reference set

Back to Start